1 Min Read
March 14 (Reuters) - Biocon Ltd
* Says reaffrims guidance of US $200 million in revenue from biosimilars in FY19 Source text - (bit.ly/2nztIMx) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.